BioGaia launches a probiotic food supplement for women before and during pregnancy

Prenatal Care is a probiotic food supplement that contains BioGaia's patented bacteria strain L. reuteri DSM 17938 along with folic acid, iron, and vitamin D3, for expecting mothers as well as women planning to conceive.

Besides BioGaia’s patented bacterial strain L. reuteri DSM 17938, one of the most scientifically well-documented probiotic strains in terms of efficacy and safety, Prenatal Care contains folic acid, iron and vitamin D3. Folic acid can support the neural tube development of the growing foetus. Iron contributes to the normal formation of red blood cells and haemoglobin and reduces fatigue and tiredness, and vitamin D can support the immune system.

"BioGaia sought to offer women a supplement that contains good bacteria, mineral and vitamins before and during their pregnancy. We know through consumer insights that women planning to conceive or who are pregnant seek safe, trustworthy, and convenient products. And Prenatal Care is the product for them", says Isabelle Ducellier, CEO at BioGaia.

The launch of Prenatal Care is planned in Sweden in Q4, 2023.

Safe to use
L. reuteri DSM 17938 is clinically tested and safe to use for the mother and the foetus.

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Mikaela Idermark Stern, Corporate Communications
Email: [email protected]
Phone: +46 730 95 61 50

About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm.